The promise and limitations of genome-wide association studies

JAMA

Volumn 308, Issue 18, 2012, Pages 1867-1868

  Klein, Christine ^a   Lohmann, Katja ^a   Ziegler, Andreas ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERINE PROTEINASE;

DNA POLYMORPHISM; EFFECT SIZE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; HIGH RISK POPULATION; HUMAN; HYDROXY 3 METHYLGLUTARYL COA REDUCTASE GENE; ISCHEMIC HEART DISEASE; LIPASE HIPATIC GENE; MAPT GENE; MULTICENTER STUDY (TOPIC); NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 GENE; RETINA MACULA AGE RELATED DEGENERATION; SAMPLE SIZE; SHORT SURVEY; SNCA GENE;

EID: 84868631803     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/2012.jama.10823     Document Type: Short Survey

References (10)

1. National Human Genome Research Institute. A catalog of published genomewide association studies. http://www.genome.gov/gwastudies. Accessed May 30, 2012.
2. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106(23):9362-9367.
3. National Human Genome Research Institute. Genome-wide association studies. http://www.genome.gov/20019523. Accessed May 30, 2012.
4. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in agerelated macular degeneration. Science. 2005;308(5720):385-389.
5. Nalls MA, Plagnol V, Hernandez DG, et al; International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377(9766):641-649.
6. Klein C, Ziegler A. From GWAS to clinical utility in Parkinson's disease. Lancet. 2011;377(9766):613-614.
7. Höglinger GU, Melhem NM, Dickson DW, et al; PSP Genetics Study Group. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011;43(7):699-705.
8. Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012;8(3):e1002548.
9. Ma L, Brautbar A, Boerwinkle E, Sing CF, Clark AG, Keinan A. Knowledgedriven analysis identifies a gene-gene interaction affecting high-density lipoprotein cholesterol levels in multi-ethnic populations. PLoS Genet. 2012;8(5):e1002714.
10. Sanna S, Li B, Mulas A, et al. Fine mapping of five loci associated with lowdensity lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet. 2011;7(7):e1002198.